Repligen Net Common Equity Issued/Repurchased 2010-2025 | RGEN

Repligen net common equity issued/repurchased for the twelve months ending March 31, 2025 was $0.010B, a 182.97% decline year-over-year.

  • Repligen annual net common equity issued/repurchased for 2024 was $0.004B, a 132.26% decline from 2023.
  • Repligen annual net common equity issued/repurchased for 2023 was $-0.013B, a 459.05% decline from 2022.
  • Repligen annual net common equity issued/repurchased for 2022 was $0.004B, a 4.43% decline from 2021.

Repligen Net Common Equity Issued/Repurchased 2010-2025 | RGEN

  • Repligen annual net common equity issued/repurchased for 2024 was $0.004B, a 132.26% decline from 2023.
  • Repligen annual net common equity issued/repurchased for 2023 was $-0.013B, a 459.05% decline from 2022.
  • Repligen annual net common equity issued/repurchased for 2022 was $0.004B, a 4.43% decline from 2021.